Rozanolixizumab

A4DAB229 | Immune-mediated / inflammatory disorders | Approved
FCGRT/FcRn
G4 / IgG4
UCB
Approved
Whole mAb
RYSTIGGO UCB-7665 UCB7665 UCB 7665
5.6
IMGT PubChem (354702273) PubChem (381127650) PubChem (404719939) PubChem (404772364) PubChem (461629178) PubChem (463599439) PubChem (472410164) PubChem (481155569) PubChem (483928629) PubChem (498151966) PubChem (500132552) Thera-SAbDab YAbS
Avg A4D Score
-0.6976
Score Range
-0.7
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB229_6fgb_H_L 6fgb 100% -0.6976 6.5 9.0 -0.3727 -0.7388